NASDAQ:CNTB

Connect Biopharma Holdings American Depositary Shares Stock Forecast

etoro logo Buy CNTB
*Your capital is at risk
$2.12
+0.0200 (+0.95%)
At Close: Jun 12, 2026
AI Analysis AI Analysis of CNTB AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add CNTB to Watchlist?
Some Reasons Why To Add CNTB:
  • +123.2% price growth over the last year
  • High gross margin of 100.0%
  • Lower volatility than the market (beta -0.21)
PDF

Green day on Friday for Connect Biopharma Holdings Ltd American stock after gaining 0.95%
(Updated on Jun 12, 2026)

Sell candidate since Jun 05, 2026 Loss -2.30%

The Connect Biopharma Holdings Ltd American stock price gained 0.95% on the last trading day (Friday, 12th Jun 2026), rising from $2.10 to $2.12. During the last trading day the stock fluctuated 5.07% from a day low at $2.07 to a day high of $2.18. The price has been going up and down for this period, and there has been a -14.86% loss for the last 2 weeks. Volume fell on the last day by -173 thousand shares and in total, 172 thousand shares were bought and sold for approximately $364.44 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.05 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -23.77% during the next 3 months and, with a 90% probability hold a price between $1.56 and $2.22 at the end of this 3-month period.

CNTB Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, June 10, 2026, and so far it has risen 1.92%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Connect Biopharma Holdings Ltd American stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.16 and $2.35. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for Connect Biopharma Holdings Ltd American stock

Connect Biopharma Holdings Ltd American finds support from accumulated volume at $2.10 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.105 between high and low, or 5.07%. For the last week the stock has had daily average volatility of 6.65%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CNTB) For The Upcoming Trading Day Of Monday 15th

For the upcoming trading day on Monday, 15th we expect Connect Biopharma Holdings Limited American Depositary Shares to open at $2.12, and during the day (based on 14 day Average True Range), to move between $2.03 and $2.21, which gives a possible trading interval of +/-$0.183 (+/-9.00%) up or down from last closing price. If Connect Biopharma Holdings Limited American Depositary Shares takes out the full calculated possible swing range there will be an estimated 9.00% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.10 (0.94%) than the resistance at $2.40 (13.21%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Connect Biopharma Holdings Limited American Depositary Shares stock A Buy?

Connect Biopharma Holdings Ltd American holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -2.850 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 15, 2026 - $2.12 ( 0.0786%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

CNTB Performance

Trading levels for CNTB

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 2.23 5.03%
R2 2.19 3.14%
R1 2.16 1.97%
Price 2.12
S1 2.08 -1.81%
S2 2.06 -2.98%
S3 2.02 -4.87%

Accumulated Volume Support & Resistance Levels

Level Price
R3 2.63 24.06%
R2 2.58 21.70%
R1 2.40 13.21%
Price 2.12
S1 2.10 -0.94%
S2 2.08 -1.89%
S3 0 -

FAQ

What is the symbol for Connect Biopharma Holdings Limited American Depositary Shares Stock and on which exchange is it traded?
The symbol for Connect Biopharma Holdings Limited American Depositary Shares is CNTB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Connect Biopharma Holdings Limited American Depositary Shares Stock?
Connect Biopharma Holdings Ltd American holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Connect Biopharma Holdings Limited American Depositary Shares Stock?
Connect Biopharma Holdings Limited American Depositary Shares Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Connect Biopharma Holdings Limited American Depositary Shares Stock.

What's the current price of Connect Biopharma Holdings Limited American Depositary Shares Stock?
As of the end of day on the Jun 12, 2026, the price of an Connect Biopharma Holdings Limited American Depositary Shares (CNTB) share was $2.12.

What is the 52-week high and low for Connect Biopharma Holdings Limited American Depositary Shares Stock?
The 52-week high for Connect Biopharma Holdings Limited American Depositary Shares Stock is $3.82 and the 52-week low is $0.80.

What is the market capitalization of Connect Biopharma Holdings Limited American Depositary Shares Stock?
As of the Jun 12, 2026, the market capitalization of Connect Biopharma Holdings Limited American Depositary Shares is 133.483M.

When is the next earnings date for Connect Biopharma Holdings Limited American Depositary Shares?
The upcoming earnings date for Connect Biopharma Holdings Limited American Depositary Shares is Aug 12, 2026.
Click to get the best stock tips daily for free!
ABOUT CONNECT BIOPHARMA HOLDINGS LIMITED AMERICAN DEPOSITARY SHARES
Connect Biopharma Holdings American Depositary Shares
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for the treatment of inflammatory allergic diseases, such as atopic dermatitis, asthma, and chronic rhinosin...
GOLDEN STAR
Ticker Change Signal Date
EAT
$140.46
13.43% Jun 05
TPR
$140.47
4.95% Jun 04
LITE
$905.00
1.83% Jun 01
RUN
$12.83
0.468% May 06
GLBE
$31.61
3.54% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE